Powder: -20°C for 3 years | In solvent: -80°C for 1 year
N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide binds to the cannabinoid 1 (CB1) receptor with a Ki value of 365 nM in a radioligand binding assay using rat brain homogenate. It has an EC50 value of 698 nM for the peroxisome proliferator-activated receptor α (PPARα) in a luciferase reporter assay and, in rats, it decreases food intake. It does not inhibit fatty acid amide hydrolase (FAAH).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 μg | 35 days | $ 93.00 | |
500 μg | 35 days | $ 394.00 | |
1 mg | 35 days | $ 693.00 |
Description | N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide binds to the cannabinoid 1 (CB1) receptor with a Ki value of 365 nM in a radioligand binding assay using rat brain homogenate. It has an EC50 value of 698 nM for the peroxisome proliferator-activated receptor α (PPARα) in a luciferase reporter assay and, in rats, it decreases food intake. It does not inhibit fatty acid amide hydrolase (FAAH). |
Molecular Weight | 431.661 |
Formula | C27H45NO3 |
CAS No. | 1258011-97-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 30 mg/mL
Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/mL
DMF: 30 mg/mL
DMSO: 25 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide 1258011-97-0 N(1(3,4Dihydroxyphenyl)propan2yl)oleamide N (1 (3,4 Dihydroxyphenyl)propan 2 yl)oleamide inhibitor inhibit